• A+ Standard
  • A+ Larger
  • A+ Extra Large

  • Standard Contrast
  • Low Contrast
  • High Contrast

Combination of the MCL1 Inhibitor PRT1419 and SMARCA2 Degrader PRT3789 Shows Combinatorial Benefit in SMARCA4-Deleted Lung Cancer

Norman Fultang, Neha Bhagwat, Diane Heiser, Alexander Grego, Michael Hulse, Venkat Thodima, Koichi Ito, Kris Vaddi, Bruce Ruggeri, Peggy Scherle

Poster presented at the

AACR Annual Meeting 2022, April 8-13, 2022, New Orleans, LA, USA

This is an electronic reproduction of a poster presented at the AACR Annual Meeting 2022, April 8-13, 2022, in New Orleans, LA, USA. All copyrights remain those of the copyright holder. This page will not be available after May 13, 2022.